Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers


  Free Subscription

Articles published in Pulm Pharmacol Ther

Retrieve available abstracts of 60 articles:
HTML format

Single Articles

    June 2021
  1. KAWAGOE J, Yuki M, Kikuchi R, Takahashi M, et al
    Differential effects of dexamethasone and roflumilast on asthma in mice with or without short cigarette smoke exposure.
    Pulm Pharmacol Ther. 2021 Jun 29:102052. doi: 10.1016/j.pupt.2021.102052.
    PubMed     Abstract available

    May 2021
  2. MOTAMED H, Verki MM, Nematollahi AV, Hesam S, et al
    Evaluation of Efficacy of Nebulized Low Molecular Weight Heparin as an Adjunctive Extra Treatment for Acute Mild-Moderate Asthma Attack; a Randomized Clinical Trial Study.
    Pulm Pharmacol Ther. 2021 May 11:102037. doi: 10.1016/j.pupt.2021.102037.
    PubMed     Abstract available

    April 2021
  3. ZOU B, Fu Y, Cao C, Pan D, et al
    Gentiopicroside ameliorates ovalbumin-induced airway inflammation in a mouse model of allergic asthma via regulating SIRT1/NF-kappaB signaling pathway.
    Pulm Pharmacol Ther. 2021 Apr 19:102034. doi: 10.1016/j.pupt.2021.102034.
    PubMed     Abstract available

  4. AKABA T, Kondo M, Kobayashi F, Honda N, et al
    Characteristics of patients with severe asthma who experienced treatment failure with omalizumab.
    Pulm Pharmacol Ther. 2021;68:102032.
    PubMed     Abstract available

    February 2021
  5. HUANG M, Wei Y, Dong J
    Epimedin C modulates the balance between Th9 cells and Treg cells through negative regulation of noncanonical NF-kappaB pathway and MAPKs activation to inhibit airway inflammation in the ovalbumin-induced murine asthma model.
    Pulm Pharmacol Ther. 2021 Feb 23:102005. doi: 10.1016/j.pupt.2021.102005.
    PubMed     Abstract available

  6. HUR J, Kang JY, Kim YK, Lee SY, et al
    Glucagon-like peptide 1 receptor (GLP-1R) agonist relieved asthmatic airway inflammation via suppression of NLRP3 inflammasome activation in obese asthma mice model.
    Pulm Pharmacol Ther. 2021 Feb 12:102003. doi: 10.1016/j.pupt.2021.102003.
    PubMed     Abstract available

    November 2020
  7. DI BONA D, Minenna E, Albanesi M, Nettis E, et al
    Benralizumab improves patient reported outcomes and functional parameters in difficult-to-treat patients with severe asthma: Data from a real-life cohort.
    Pulm Pharmacol Ther. 2020;64:101974.
    PubMed     Abstract available

    October 2020
  8. BUSBY J, Holweg C, Chai A, Bradding P, et al
    Using prednisolone and cortisol assays to assess adherence in oral corticosteroid dependant asthma: an analysis of test-retest repeatability.
    Pulm Pharmacol Ther. 2020 Oct 9:101951. doi: 10.1016/j.pupt.2020.101951.
    PubMed     Abstract available

  9. MATSUNO O, Minamoto S
    Rapid effect of benralizumab for severe asthma with chronic rhinosinusitis with nasal polyps.
    Pulm Pharmacol Ther. 2020;64:101965.
    PubMed     Abstract available

  10. MENZELLA F, Ruggiero P, Galeone C, Scelfo C, et al
    Significant improvement in lung function and asthma control after benralizumab treatment for severe refractory eosinophilic asthma.
    Pulm Pharmacol Ther. 2020;64:101966.
    PubMed     Abstract available

  11. LI Y, Li X, Zhou W, Yu Q, et al
    ORMDL3 modulates airway epithelial cell repair in children with asthma under glucocorticoid treatment via regulating IL-33.
    Pulm Pharmacol Ther. 2020 Oct 6:101963. doi: 10.1016/j.pupt.2020.101963.
    PubMed     Abstract available

    September 2020
  12. ASANO K, Sumi K, Yoshisue H, Nakamura N, et al
    Real-life safety and efficacy of omalizumab in Japanese patients with severe allergic asthma who were subjected to dosing table revision or expansion: A post-marketing surveillance.
    Pulm Pharmacol Ther. 2020 Sep 17:101950. doi: 10.1016/j.pupt.2020.101950.
    PubMed     Abstract available

  13. RENNER A, Marth K, Patocka K, Idzko M, et al
    Effectiveness of mepolizumab therapy in patients with severe eosinophilic asthma: Austrian real-life data.
    Pulm Pharmacol Ther. 2020;64:101946.
    PubMed     Abstract available

    August 2020
  14. WANG J, Sun H, Liu Y
    The proliferative and anti-apoptosis functions of KGF/KGFR contributes to bronchial epithelial repair in asthma.
    Pulm Pharmacol Ther. 2020 Aug 17:101931. doi: 10.1016/j.pupt.2020.101931.
    PubMed     Abstract available

  15. DOGAN MF, Parlar A, Cam SA, Tosun EM, et al
    Glabridin attenuates airway inflammation and hyperresponsiveness in a mice model of ovalbumin-induced asthma.
    Pulm Pharmacol Ther. 2020 Aug 9:101936. doi: 10.1016/j.pupt.2020.101936.
    PubMed     Abstract available

    May 2020
  16. BUHL R, Tanase AM, Hosoe M, Cao W, et al
    A randomized, double-blind study to compare the efficacy and safety of two doses of mometasone furoate delivered via Breezhaler(R) or Twisthaler(R) in patients with asthma.
    Pulm Pharmacol Ther. 2020 May 6:101919. doi: 10.1016/j.pupt.2020.101919.
    PubMed     Abstract available

    April 2020
  17. ELGENDY MO, Hassan AH, Saeed H, Abdelrahim ME, et al
    Asthmatic children and MDI verbal inhalation technique counseling.
    Pulm Pharmacol Ther. 2020;61:101900.
    PubMed     Abstract available

  18. SPOSATO B, Camiciottoli G, Bacci E, Scalese M, et al
    Mepolizumab effectiveness on small airway obstruction, corticosteroid sparing and maintenance therapy step-down in real life.
    Pulm Pharmacol Ther. 2020;61:101899.
    PubMed     Abstract available

    February 2020
  19. YI F, Han L, Liu B, Zhang X, et al
    Determinants of response to bronchodilator in patients with cough variant asthma- A randomized, single-blinded, placebo-controlled study.
    Pulm Pharmacol Ther. 2020 Feb 21:101903. doi: 10.1016/j.pupt.2020.101903.
    PubMed     Abstract available

  20. CARPAGNANO GE, Scioscia G, Lacedonia D, Stornelli SR, et al
    Treatment response according to small airways disease status: The effects of high-strength extrafine pMDI beclomethasone dipropionate/formoterol fumarate in fixed dose combination in moderate uncontrolled asthmatic patients.
    Pulm Pharmacol Ther. 2020;60:101879.
    PubMed     Abstract available

    January 2020
  21. ALIZADEH Z, Mortaz E, Mazinani M, Fazlollahi MR, et al
    Asthma phenotypes and T-bet protein expression in cells treated with Fluticasone Furoate/Vilanterol.
    Pulm Pharmacol Ther. 2020 Jan 6:101886. doi: 10.1016/j.pupt.2020.101886.
    PubMed     Abstract available

    December 2019
  22. CALZETTA L, Matera MG, Goldstein MF, Fairweather WR, et al
    A long-term clinical trial on the efficacy and safety profile of doxofylline in Asthma: The LESDA study.
    Pulm Pharmacol Ther. 2019 Dec 26:101883. doi: 10.1016/j.pupt.2019.101883.
    PubMed     Abstract available

  23. KARAMPITSAKOS T, Hillas G, Zervas E, Bakakos P, et al
    Prospective evaluation for inhalation devices in greek patients with COPD and asthma: The PAIR study.
    Pulm Pharmacol Ther. 2019 Dec 24:101882. doi: 10.1016/j.pupt.2019.101882.
    PubMed     Abstract available

  24. BUHL R, FitzGerald JM, Meltzer EO, de la Hoz A, et al
    Efficacy of once-daily tiotropium Respimat in adults with asthma at GINA Steps 2-5.
    Pulm Pharmacol Ther. 2019;60:101881.
    PubMed     Abstract available

  25. MENZELLA F, Galeone C, Ruggiero P, Bagnasco D, et al
    Biologics and Bronchial Thermoplasty for severe refractory asthma treatment: From eligibility criteria to real practice. A cross-sectional study.
    Pulm Pharmacol Ther. 2019;60:101874.
    PubMed     Abstract available

  26. SINGH D, Khan N, Dean J, Fowler A, et al
    FEV1 recovery following methacholine challenge in asthma: Variability and comparison of methods.
    Pulm Pharmacol Ther. 2019 Dec 13:101876. doi: 10.1016/j.pupt.2019.101876.
    PubMed     Abstract available

  27. THALANAYAR MUTHUKRISHNAN P, Nouraie M, Parikh A, Holguin F, et al
    Zileuton use and phenotypic features in asthma.
    Pulm Pharmacol Ther. 2019 Dec 10:101872. doi: 10.1016/j.pupt.2019.101872.
    PubMed     Abstract available

    November 2019
  28. GHOSHAL A, Waghray P, Dsouza G, Saluja M, et al
    Real-world evaluation of the clinical safety and efficacy of fluticasone/formoterol FDC via the Revolizer(R) in patients with persistent asthma in India.
    Pulm Pharmacol Ther. 2019 Nov 30:101869. doi: 10.1016/j.pupt.2019.101869.
    PubMed     Abstract available

  29. NIIMI A, Fukumitsu K, Takeda N, Kanemitsu Y, et al
    Interfering with airway nerves in cough associated with asthma.
    Pulm Pharmacol Ther. 2019 Nov 1:101854. doi: 10.1016/j.pupt.2019.101854.
    PubMed     Abstract available

    July 2019
  30. MATERA MG, Rinaldi B, Calzetta L, Rogliani P, et al
    Pharmacokinetics and pharmacodynamics of inhaled corticosteroids for asthma treatment.
    Pulm Pharmacol Ther. 2019 Jul 23:101828. doi: 10.1016/j.pupt.2019.101828.
    PubMed     Abstract available

  31. PELAIA C, Busceti MT, Vatrella A, Rago GF, et al
    Real-life rapidity of benralizumab effects in patients with severe allergic eosinophilic asthma: Assessment of blood eosinophils, symptom control, lung function and oral corticosteroid intake after the first drug dose.
    Pulm Pharmacol Ther. 2019 Jul 22:101830. doi: 10.1016/j.pupt.2019.101830.
    PubMed     Abstract available

    June 2019
  32. BJERMER L, Abbott-Banner K, Newman K
    Efficacy and safety of a first-in-class inhaled PDE3/4 inhibitor (ensifentrine) vs salbutamol in asthma.
    Pulm Pharmacol Ther. 2019 Jun 13:101814. doi: 10.1016/j.pupt.2019.101814.
    PubMed     Abstract available

  33. QI Y, Fang L, Stolz D, Tamm M, et al
    Long acting beta2-agonist's activation of cyclic AMP cannot halt ongoing mitogenic stimulation in airway smooth muscle cells.
    Pulm Pharmacol Ther. 2019;56:20-28.
    PubMed     Abstract available

  34. KANTAR A, Seminara M
    Why chronic cough in children is different.
    Pulm Pharmacol Ther. 2019;56:51-55.
    PubMed     Abstract available

    April 2019
  35. BOULET LP, Turmel J
    Cough in exercise and athletes.
    Pulm Pharmacol Ther. 2019;55:67-74.
    PubMed     Abstract available

    February 2019
  36. ZHANG LB, He M
    Effect of mesenchymal stromal (stem) cell (MSC) transplantation in asthmatic animal models: A systematic review and meta-analysis.
    Pulm Pharmacol Ther. 2019;54:39-52.
    PubMed     Abstract available

    January 2019
  37. MANDAL J, Roth M, Papakonstantinou E, Fang L, et al
    Adrenomedullin mediates pro-angiogenic and pro-inflammatory cytokines in asthma and COPD.
    Pulm Pharmacol Ther. 2019 Jan 25. pii: S1094-5539(18)30186.
    PubMed     Abstract available

  38. JAVOR E, Grle SP
    Limitations of the results from randomized clinical trials involving intravenous and nebulised magnesium sulphate in adults with severe acute asthma.
    Pulm Pharmacol Ther. 2019 Jan 17. pii: S1094-5539(18)30082.
    PubMed     Abstract available

    December 2018
  39. LOMBARDI C, Bagnasco D, Caruso C, D'Amato M, et al
    Analysis of the drop-out rate in patients receiving mepolizumab for severe asthma in real life.
    Pulm Pharmacol Ther. 2018 Dec 28. pii: S1094-5539(18)30277.
    PubMed     Abstract available

    November 2018
  40. PELAIA C, Calabrese C, Barbuto S, Busceti MT, et al
    Omalizumab lowers asthma exacerbations, oral corticosteroid intake and blood eosinophils: Results of a 5-YEAR single-centre observational study.
    Pulm Pharmacol Ther. 2018 Nov 7. pii: S1094-5539(18)30245.
    PubMed     Abstract available

    September 2018
  41. SULAIMAN I, Tan K, Mohtarrudin N, Woei Lim JC, et al
    Andrographolide prevented toluene diisocyanate-induced occupational asthma and aberrant airway E-cadherin distribution via p38 MAPK-dependent Nrf2 induction.
    Pulm Pharmacol Ther. 2018 Sep 20. pii: S1094-5539(18)30150.
    PubMed     Abstract available

  42. CALZETTA L, Hanania NA, Dini FL, Goldstein MF, et al
    Impact of doxofylline compared to theophylline in asthma: A pooled analysis of functional and clinical outcomes from two multicentre, double-blind, randomised studies (DOROTHEO 1 and DOROTHEO 2).
    Pulm Pharmacol Ther. 2018 Sep 13. pii: S1094-5539(18)30182.
    PubMed     Abstract available

  43. PELAIA C, Busceti MT, Solinas S, Terracciano R, et al
    Real-life evaluation of the clinical, functional, and hematological effects of mepolizumab in patients with severe eosinophilic asthma: Results of a single-centre observational study.
    Pulm Pharmacol Ther. 2018 Sep 11. pii: S1094-5539(18)30212.
    PubMed     Abstract available

    August 2018
  44. MASELLI DJ, Hanania NA
    Asthma COPD overlap: Impact of associated comorbidities.
    Pulm Pharmacol Ther. 2018 Aug 30. pii: S1094-5539(18)30142.
    PubMed     Abstract available

    A proposed scheme to cope with comorbidities in asthma.
    Pulm Pharmacol Ther. 2018 Aug 24. pii: S1094-5539(18)30137.
    PubMed     Abstract available

    July 2018
  46. BUDDE J, Skloot GS
    Is aging a "comorbidity" of asthma?
    Pulm Pharmacol Ther. 2018 Jul 4. pii: S1094-5539(18)30138.
    PubMed     Abstract available

  47. HASSALL D, Brealey N, Wright W, Hughes S, et al
    Hair analysis to monitor adherence to prescribed chronic inhaler drug therapy in patients with asthma or COPD.
    Pulm Pharmacol Ther. 2018 Jul 4. pii: S1094-5539(18)30084.
    PubMed     Abstract available

    June 2018
  48. LUCZAK-WOZNIAK K, Dabrowska M, Domagala I, Miszczuk M, et al
    Mishandling of pMDI and DPI inhalers in asthma and COPD - Repetitive and non-repetitive errors.
    Pulm Pharmacol Ther. 2018 Jun 28. pii: S1094-5539(18)30076.
    PubMed     Abstract available

    Overreliance link between asthmatic subjects and short-acting beta2 agonists.
    Pulm Pharmacol Ther. 2018;50:80-81.
    PubMed     Abstract available

    April 2018
  50. SCADUTO F, Giglio RV, Benfante A, Nikolic D, et al
    Serum lipoproteins are not associated with the severity of asthma.
    Pulm Pharmacol Ther. 2018 Apr 4. pii: S1094-5539(18)30052.
    PubMed     Abstract available

    February 2018
  51. JOHANSSON EL, Ternesten-Hasseus E, Gustafsson P, Pullerits T, et al
    Small and large airway reactions to osmotic stimuli in asthma and chronic idiopathic cough.
    Pulm Pharmacol Ther. 2018 Feb 10. pii: S1094-5539(17)30291.
    PubMed     Abstract available

  52. KACZYNSKA K, Zajac D, Wojciechowski P, Kogut E, et al
    Neuropeptides and breathing in health and disease.
    Pulm Pharmacol Ther. 2018;48:217-224.
    PubMed     Abstract available

  53. AKABA T, Komiya K, Suzaki I, Kozaki Y, et al
    Activating prostaglandin E2 receptor subtype EP4 increases secreted mucin from airway goblet cells.
    Pulm Pharmacol Ther. 2018;48:117-123.
    PubMed     Abstract available

  54. HUR J, Kang JY, Rhee CK, Kim YK, et al
    The leukotriene receptor antagonist pranlukast attenuates airway remodeling by suppressing TGF-beta signaling.
    Pulm Pharmacol Ther. 2018;48:5-14.
    PubMed     Abstract available

    December 2017
  55. SOULELE K, Macheras P, Karalis V
    On the pharmacokinetics of two inhaled budesonide/formoterol combinations in asthma patients using modeling approaches.
    Pulm Pharmacol Ther. 2017 Dec 6. pii: S1094-5539(17)30180.
    PubMed     Abstract available

    October 2017
    Cough and severe asthma.
    Pulm Pharmacol Ther. 2017 Oct 3. pii: S1094-5539(17)30149.

    September 2017
  57. BALKI A, Balamurugan S, Bardapurkar S, Dalal S, et al
    Comparison of fluticasone/formoterol with budesonide/formoterol pMDI in adults with moderate to severe persistent asthma: Results from a 12-week randomized controlled trial.
    Pulm Pharmacol Ther. 2017 Sep 7. pii: S1094-5539(17)30099.
    PubMed     Abstract available

    June 2017
  58. BENFANTE A, Messina R, Milazzo V, Scichilone N, et al
    How to unveil chronic respiratory diseases in clinical practice? A model of alliance between general practitioners and pulmonologists.
    Pulm Pharmacol Ther. 2017;44:106-110.
    PubMed     Abstract available

  59. SPOSATO B, Scalese M, Latorre M, Novelli F, et al
    Can the response to Omalizumab be influenced by treatment duration? A real-life study.
    Pulm Pharmacol Ther. 2017;44:38-45.
    PubMed     Abstract available

    February 2017
  60. CHEN M, Shi J, Zhang W, Huang L, et al
    MiR-23b controls TGF-beta1 induced airway smooth muscle cell proliferation via direct targeting of Smad3.
    Pulm Pharmacol Ther. 2017;42:33-42.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Asthma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.